
|Articles|February 15, 2003
- BioPharm International-02-01-2003
- Volume 16
- Issue 2
Becoming a Partner of Choice and Evaluating Prospective Alliances
Author(s)Jan Heybroek, David Wallis
by David Wallis, Dechert and Jan Heybroek Whether you're on the inlicensing or outlicensing side of a collaboration, attention must be paid to putting forth the right image and learning about your prospective partners before the alliance is struck.
Advertisement
Articles in this issue
over 22 years ago
Guest Editorial: Maybe You Need a Corporate Marriage Counselorover 22 years ago
Inside Washington: AIDS Prevention Campaign Spotlights Biotechover 22 years ago
Survival Strategies: Keeping Tabs on Trainingover 22 years ago
Outsourcing Outlook: Contract Services' Crystal BallNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
2
Distribution Resilience: Meeting Global Demand and Delivering Faster, More Reliable Service
3
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
4
Scaling Manufacturing of Novel Therapies
5





